Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy.

@article{Abramson2000CosteffectivenessOH,
  title={Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy.},
  author={Richard G. Abramson and Max P. Rosen and Laura J. Perry and David P. Brophy and S L Raeburn and Keith E. Stuart},
  journal={Radiology},
  year={2000},
  volume={216 2},
  pages={
          485-91
        }
}
PURPOSE To calculate the cost-effectiveness of hepatic arterial chemoembolization (HACE) for the treatment of colorectal liver metastases (CLM) over a range of survival benefits and to determine the survival benefit that HACE must confer to meet three thresholds of cost-effectiveness. MATERIALS AND METHODS A spreadsheet model was used to estimate the marginal direct cost of HACE compared with palliative care from a payer's perspective. Medicare reimbursement amounts represented costs, while… 
View on PubMed
chemoemboli.ru
27 Citations
Background Citations
7

27 Citations

Citation Type

Citation Type

Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms.
Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update
TLDR
An overview of the techniques, indications and results of regional chemotherapy, which comprises transarterial chemoembolization (TACE) and chemoperfusion of colorectal liver metastases, is provided.
The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.
TLDR
There is currently limited high-quality research evidence upon which to base any firm decisions regarding ablative therapies for liver metastases, with microwave ablation being associated with reduced cost but also with poorer outcome than surgery.
Predicting survival in patients with liver cancer considered for transarterial chemoembolization.
A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC).
  • C. Panje, K. Dedes, +6 authors J. Lupatsch
  • Medicine, Political Science
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2018
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.
TLDR
Data show that diabetes mellitus and the presence of bilioenteric anastomosis are risk factors for developing complications after TACE, and the use of new drug-eluting microspheres did not increase the risk of complications.
Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver.
TLDR
Although an association of response with improved survival was not demonstrated, large cohort studies are necessary to further define this relationship and TACE appears to be superior to TAE.
Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report
TLDR
Chemoembolization using Irinotecan loaded beads was safe and effective in the treatment of patients as demonstrated by a minimal complication rate and acceptable tumor response.
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
TLDR
TACE with oxaliplatin-loaded microspheres is a safe and feasible treatment without major adverse events and with a favorable pharmacokinetic profile.
Cost Accounting as a Tool for Increasing Cost Transparency in Selective Hepatic Transarterial Chemoembolization.
...
1
2
3
...

References

SHOWING 1-10 OF 38 REFERENCES
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma
TLDR
Chemoembolization of hepatic metastases in colorectal cancer should be further evaluated; it may be beneficial in patients who have failed systemic chemotherapy, have a good performance status, and have metastatic disease confined to the liver.
Considerable side effects of chemoembolization for colorectal carcinoma metastatic to the liver.
The feasibility of one whole liver chemoembolization (CE) procedure with Angiostat, a vasoocclusive collagen, mitomycin, doxorubicin, and cisplatin was evaluated in eight patients with unresectable…
Colorectal metastases to the liver: selective chemoembolization.
TLDR
Selective chemoembolization is recommended for treatment of patients with colorectal metastases to the liver, a resectable primary tumor, and no evidence of other metastatic disease.
Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors.
Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: Post‐treatment management and complications
TLDR
Complications and patient management issues associated with hepatic arterial chemoembolization and embolization used to treat liver malignancies and characterizes patient survival based on histologic tumor type are described.
Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate.
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma.
TLDR
In a group of patients with unresectable hepatocellular carcinoma but without severe liver disease, lipiodol chemoembolization reduced tumor growth, often caused acute liver failure, and did not significantly improve survival.
Chemoembolization for hepatocellular carcinoma.
  • A. Venook, R. Stagg, +4 authors D. Hohn
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1990
TLDR
Gelfoam chemoembolization appears to have significant activity in patients with hepatocellular carcinoma and is relatively well tolerated.
Transcatheter chemoembolization of progressive carcinoid liver metastasis.
TLDR
Chemoembolization is safe and effective for palliation of carcinoid liver metastases from carcinoid tumor with doxorubicin, iodized oil, and gelatin sponge embolization.
...
1
2
3
4
...